Sereflo is a prescription medication commonly used in the management and treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a combination inhaler that contains two active ingredients: fluticasone propionate, a corticosteroid that reduces inflammation in the lungs, and salmeterol xinafoate, a long-acting beta2-adrenergic agonist (LABA) that helps to relax the muscles around the airways in the lungs, making it easier to breathe. Sereflo is typically prescribed for patients who need regular treatment to control their breathing difficulties, and it is used as a maintenance therapy rather than a rescue treatment for sudden asthma attacks. Patients are advised to use Sereflo regularly as prescribed by their healthcare provider to achieve optimal control over their respiratory conditions.